Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
12.36
-0.09 (-0.72%)
At close: Jul 19, 2024, 4:00 PM
12.35
-0.01 (-0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Pliant Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Pliant Therapeutics stock have an average target of 46, with a low estimate of 36 and a high estimate of 63. The average target predicts an increase of 272.17% from the current stock price of 12.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PLRX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 4 | 3 | 3 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +207.44% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +191.26% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +191.26% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +191.26% | May 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +207.44% | May 7, 2024 |
Financial Forecast
Revenue This Year
575.73K
from 1.58M
Decreased by -63.56%
Revenue Next Year
3.26M
from 575.73K
Increased by 466.41%
EPS This Year
-3.47
from -2.75
EPS Next Year
-3.79
from -3.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.2M | 21.0M | 21.0M | 199.8M | 733.5M |
| Avg | 575,729 | 3.3M | 5.3M | 36.9M | 169.5M |
| Low | n/a | n/a | n/a | n/a | 19.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 99.4% | 3,547.6% | 544.0% | 3,648.4% | 1,889.8% |
| Avg | -63.6% | 466.4% | 63.4% | 591.6% | 359.9% |
| Low | - | - | - | - | -46.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.30 | -3.14 | -3.58 | -1.48 | 5.41 |
| Avg | -3.47 | -3.79 | -4.01 | -3.34 | -1.75 |
| Low | -3.72 | -4.36 | -4.87 | -4.21 | -4.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.